Ninth International Congress of Neuroimmunology

第九届国际神经免疫学大会

基本信息

  • 批准号:
    7614128
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-30 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application requests partial support for the 9th International Congress of the International Society of Neuroimmunology sponsored by the International Society of Neuroimmunology (ISNI), which will take place in Fort Worth, Texas, from October 26 - 30, 2008. This will be the first Congress held in the United States since the 2nd International Congress held in Philadelphia in 1987. The congress will be preceded by a pre-congress program sponsored by the European School of Neuroimmunology, represented by leaders in the field of neuroimmunology. Drs. Michael K. Racke and Caroline C. Whitacre, are the Congress co-organizers. Dr. Whitacre is currently the Society's Vice-President and will become the President of ISNI at this meeting. She is a member of the International Advisory Committee of the Congress. The funds requested will be used by the congress organizers to encourage the attendance of junior and minority investigators in the field of Neuroimmunology. This congress is the major event in the international neuroimmunology calendar and is held every 2 or 3 years. Anticipated attendance is 1,200-1,500. Our 2004 ISNI Congress in Venice hosted 1200+ attendees and Nagoya in 2006, 1000+ attendees. Due to the increasing recognition of the key role of the immune system in many neurological diseases, neuroimmunology has become an important and continuously expanding biomedical field, encompassing a wide variety of disciplines ranging from genetics, basic immunology and neurobiology, through neurochemistry, pharmacology, endocrinology, neuropathology and neuroimmunomodulation, to clinical immunology and neurology. The scientific program will focus on basic mechanisms of immune surveillance, including new techniques in neuroimaging, repair of the nervous system, nervous system regulation of immune responses, and immunologic mechanisms of neurologic diseases. A heavy emphasis on new therapeutic approaches (gene, cell and immune-based therapies) in neurologic diseases (multiple sclerosis, gliomas, paraneoplastic syndromes, neuromuscular disorders, psychiatric disease, HIV encephalitis, viral infections, etc.), will permeate the program. Stem cell research in neural repair and mechanisms of neurodegeneration will also feature prominently. This request is for travel funds and will be used to encourage young and minority investigators (pre- and postdoctoral) to attend from around the world, in particular from less developed countries. The selection of candidates will be carried out by a local organizing committee in the United States. Because of the heavy emphasis on translational research, Continuing Medical Education credits will be offered at the congress and support will be requested to cover the costs associated with the administration of disclosure information and the overall accreditation process, which will ensure all congress presentations are balanced and free of bias for the participants. PUBLIC HEALTH RELEVANCE: Neuroimmunology is of great relevance to most degenerative neurologic conditions because the nervous system is in constant communication with the immune system and responds to almost any type of stress. The nervous system produces molecules that interact with the immune system and vice-versa, leading to important interactions when inflammation occurs in the nervous system. Neuroimmunology has tremendous relevance to public health in that immune responses can be either blocked or modulated thus making them amenable to therapy. The enormous strides made in multiple sclerosis and Alzheimer's disease in recent years have evolved from the application of therapeutic strategies that grew out of neuroimmunologic investigations.
描述(由申请人提供):本申请要求对国际神经免疫学会第9届国际神经免疫学会(ISNI)赞助的国际神经免疫学会(ISNI)赞助,该学会将于2008年10月26日至30日在得克萨斯州沃思堡举行。这将是第2届国际大会在美国举行的国际大会,该国会将于1987年召开。由欧洲神经免疫学院赞助的国会前计划由神经免疫学领域的领导者代表。博士。 Michael K. Racke和Caroline C. Whitacre是国会共同组织者。 Whitacre博士目前是该协会的副主席,将在这次会议上成为ISNI的主席。她是国会国际咨询委员会的成员。国会组织者将使用所要求的资金来鼓励在神经免疫学领域的初级和少数民族调查员的出席。该国会是国际神经免疫日历中的主要事件,每2或3年举行一次。预期出勤率为1,200-1,500。我们2004年在威尼斯的ISNI国会大会于2006年接待了1200多名与会者和名古屋,1000多名与会者。由于对免疫系统在许多神经疾病中的关键作用的认识日益增加,神经免疫学已成为一个重要且不断扩展的生物医学领域,包括遗传学,基本免疫学和神经生物学,通过神经化学,神经化学,神经学,神经学和神经学,神经疗法,神经疗法和神经学,神经疗法和神经学,神经疗法和神经学,神经疗法和神经学,神经疗法和神经疗法,神经学,神经疗法和神经疗法,神经学,神经疗法,神经疗法和神经疗法,神经学和神经学疗法,良好。神经病学。科学计划将重点介绍免疫监测的基本机制,包括神经影像学中的新技术,神经系统修复,神经系统的调节免疫反应以及神经疾病的免疫学机制。在神经系统疾病(多发性硬化症,胶质瘤,副肿瘤综合征,神经肌肉疾病,精神疾病,HIV性疾病,HIV脑炎,病毒感染等)中,非常重视新的治疗方法(基因,细胞和基于免疫疗法)(多发性硬化症,胶质瘤,副肿瘤综合征,神经肌肉疾病,等)。神经修复中的干细胞研究和神经退行性机制也将显着。该要求是提供旅行资金,并将用于鼓励年轻和少数族裔调查人员(前后)来自世界各地的人,尤其是来自较不发达国家的人。候选人的选择将由美国的当地组织委员会进行。由于对转化研究的重视程度,将在国会提供持续的医学教育学分,并要求支持与披露信息管理和整体认证过程相关的费用,这将确保所有国会的演讲平衡并没有偏见的参与者。 公共卫生相关性:神经免疫学与大多数退化性神经系统疾病具有很大的相关性,因为神经系统正在与免疫系统持续沟通,并且几乎对任何类型的压力做出了反应。神经系统会产生与免疫系统相互作用的分子,反之亦然,当神经系统中炎症发生时,会导致重要的相互作用。神经免疫学与公共卫生具有巨大的相关性,因为可以阻止或调节免疫反应,从而使其适合治疗。近年来,在多发性硬化症和阿尔茨海默氏病中取得了巨大的进步源于从神经免疫学研究中得出的治疗策略的应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL K RACKE其他文献

MICHAEL K RACKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL K RACKE', 18)}}的其他基金

CLINICAL TRIAL: BETASERON/BETAFERON IN MS
临床试验:BETASERON/BETAFERON 在 MS 中的应用
  • 批准号:
    7718677
  • 财政年份:
    2007
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6748111
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7497835
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6614757
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6884627
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7238737
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7052790
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6085879
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6170766
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6374448
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:

相似海外基金

ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
  • 批准号:
    10753675
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Racial/Ethnic Disparities in Health Care and Challenges in Insurance Plan Choices among Older People with Alzheimer’s Disease and Related Dementia: A Mixed Methods Study of Medicare Options
患有阿尔茨海默病和相关痴呆症的老年人在医疗保健方面的种族/民族差异以及保险计划选择的挑战:医疗保险选项的混合方法研究
  • 批准号:
    10723148
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730131
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10729952
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730060
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了